- Home
- Equipment
- australasia
- cancer diagnostic
Refine by
Cancer Diagnostic Equipment Supplied In Australasia
4 equipment items found
by:Starpharma Holdings Limited based inMelbourne, AUSTRALIA
DEP® radiotheranostic conjugates have the potential to minimise off-target toxicity, optimise pharmacokinetics and enhance efficacy when used alone or in combination with other therapeutic approaches. The versatility of Starpharma’s DEP® platform means it can be used with a wide range of therapies and types of molecules (e.g., small molecule drugs, peptides, antibodies, ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
EXO-NET RUO - a pan-exosome capture tool for isolation of exosomes from body fluids including plasma, urine, and saliva. Exosomes are small membrane-enclosed vesicles actively secreted by most cells into biological fluids including serum, plasma, urine, breast milk, and saliva [1]. Studies have found that the analysis of exosome-associated nucleic acids, proteins and/or lipids can indicate the ...
Manufactured by:Biotronik SE & Co. KG based inBerlin, GERMANY
For many years, patients with a pacemaker, ICD or CRT device, have been denied access to MRI. The cardiac devices were not approved for MRI scanning and the influence of magnetic resonance imaging on implanted cardiac systems was not yet ...